169 related articles for article (PubMed ID: 36947020)
21. The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.
Cherry MG; Greenhalgh J; Osipenko L; Venkatachalam M; Boland A; Dundar Y; Marsh K; Dickson R; Rees DC
Health Technol Assess; 2012; 16(43):1-129. PubMed ID: 23140544
[TBL] [Abstract][Full Text] [Related]
22. Personalized Reminders Increase Screening for Stroke Risk in Children with Sickle Cell Anemia.
Muntz DS; Bundy DG; Strouse JJ
South Med J; 2016 Sep; 109(9):506-10. PubMed ID: 27598350
[TBL] [Abstract][Full Text] [Related]
23. High deductible health plans and spending among families with a substance use disorder.
Meiselbach MK; Kennedy-Hendricks A; Schilling C; Busch AB; Huskamp HA; Stuart EA; Hollander MAG; Barry CL; Eisenberg MD
Drug Alcohol Depend; 2022 Dec; 241():109681. PubMed ID: 36370532
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of a comprehensive transcranial doppler screening program for children with sickle cell anemia.
McCarville MB; Goodin GS; Fortner G; Li CS; Smeltzer MP; Adams R; Wang W
Pediatr Blood Cancer; 2008 Apr; 50(4):818-21. PubMed ID: 18085672
[TBL] [Abstract][Full Text] [Related]
25. Out-of-Pocket Costs and Outpatient Visits Among Patients With Cancer in High-Deductible Health Plans.
Trad NK; Zhang F; Wharam JF
JAMA Oncol; 2024 Mar; 10(3):390-394. PubMed ID: 38236593
[TBL] [Abstract][Full Text] [Related]
26. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.
Ware RE; Davis BR; Schultz WH; Brown RC; Aygun B; Sarnaik S; Odame I; Fuh B; George A; Owen W; Luchtman-Jones L; Rogers ZR; Hilliard L; Gauger C; Piccone C; Lee MT; Kwiatkowski JL; Jackson S; Miller ST; Roberts C; Heeney MM; Kalfa TA; Nelson S; Imran H; Nottage K; Alvarez O; Rhodes M; Thompson AA; Rothman JA; Helton KJ; Roberts D; Coleman J; Bonner MJ; Kutlar A; Patel N; Wood J; Piller L; Wei P; Luden J; Mortier NA; Stuber SE; Luban NLC; Cohen AR; Pressel S; Adams RJ
Lancet; 2016 Feb; 387(10019):661-670. PubMed ID: 26670617
[TBL] [Abstract][Full Text] [Related]
27. Utilization and Spending With Preventive Drug Lists for Asthma Medications in High-Deductible Health Plans.
Sinaiko AD; Ross-Degnan D; Wharam JF; LeCates RF; Wu AC; Zhang F; Galbraith AA
JAMA Netw Open; 2023 Aug; 6(8):e2331259. PubMed ID: 37642963
[TBL] [Abstract][Full Text] [Related]
28. Comparison of transcranial color Doppler imaging (TCDI) and transcranial Doppler (TCD) in children with sickle-cell anemia.
Jones AM; Seibert JJ; Nichols FT; Kinder DL; Cox K; Luden J; Carl EM; Brambilla D; Saccente S; Adams RJ
Pediatr Radiol; 2001 Jul; 31(7):461-9. PubMed ID: 11486797
[TBL] [Abstract][Full Text] [Related]
29. The impact of HDHPs on service use and spending for substance use disorders.
Eisenberg MD; Kennedy-Hendricks A; Schilling C; Busch AB; Huskamp HA; Stuart EA; Meiselbach MK; Barry CL
Am J Manag Care; 2022 Oct; 28(10):530-536. PubMed ID: 36252172
[TBL] [Abstract][Full Text] [Related]
30. Neurocognitive functioning in children with sickle cell anemia and history of abnormal transcranial doppler ultrasonography.
Longoria JN; Wang W; Kang G; Gossett J; Krull K; King AA; Raches D; Schreiber J; Heitzer AM; Hankins JS
Pediatr Blood Cancer; 2022 Nov; 69(11):e29943. PubMed ID: 36031725
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of High-Deductible Health Plans and Acute Glycemic Complications Among Adults With Diabetes.
Jiang DH; Herrin J; Van Houten HK; McCoy RG
JAMA Netw Open; 2023 Jan; 6(1):e2250602. PubMed ID: 36662531
[TBL] [Abstract][Full Text] [Related]
32. Transcranial Doppler screening for stroke risk in children with sickle cell disease: a systematic review.
Mazzucco S; Diomedi M; Qureshi A; Sainati L; Padayachee ST
Int J Stroke; 2017 Aug; 12(6):580-588. PubMed ID: 28440126
[TBL] [Abstract][Full Text] [Related]
33. Implementation of a Process for Initial Transcranial Doppler Ultrasonography in Children With Sickle Cell Anemia.
Crosby LE; Joffe NE; Davis B; Quinn CT; Shook L; Morgan D; Simmons K; Kalinyak KA
Am J Prev Med; 2016 Jul; 51(1 Suppl 1):S10-6. PubMed ID: 27320459
[TBL] [Abstract][Full Text] [Related]
34. Vital Signs: Use of Recommended Health Care Measures to Prevent Selected Complications of Sickle Cell Anemia in Children and Adolescents - Selected U.S. States, 2019.
Schieve LA; Simmons GM; Payne AB; Abe K; Hsu LL; Hulihan M; Pope S; Rhie S; Dupervil B; Hooper WC
MMWR Morb Mortal Wkly Rep; 2022 Sep; 71(39):1241-1246. PubMed ID: 36173745
[TBL] [Abstract][Full Text] [Related]
35. Genetic risk factors for cerebrovascular disease in children with sickle cell disease: design of a case-control association study and genomewide screen.
Adams GT; Snieder H; McKie VC; Clair B; Brambilla D; Adams RJ; Kutlar F; Kutlar A
BMC Med Genet; 2003 Jul; 4():6. PubMed ID: 12871600
[TBL] [Abstract][Full Text] [Related]
36. Do high-deductible health plans affect price paid for childbirth?
Cliff BQ
Health Serv Res; 2022 Feb; 57(1):27-36. PubMed ID: 34254295
[TBL] [Abstract][Full Text] [Related]
37. Stroke prevention in the young child with sickle cell anaemia.
Roberts L; O'Driscoll S; Dick MC; Height SE; Deane C; Goss DE; Pohl K; Rees DC
Ann Hematol; 2009 Oct; 88(10):943-6. PubMed ID: 19455330
[TBL] [Abstract][Full Text] [Related]
38. Association of alpha-thalassemia and Glucose-6-Phosphate Dehydrogenase deficiency with transcranial Doppler ultrasonography in Nigerian children with sickle cell anemia.
Ojewunmi OO; Adeyemo TA; Oyetunji AI; Benn Y; Ekpo MG; Iwalokun BA
J Clin Lab Anal; 2021 Jun; 35(6):e23802. PubMed ID: 33938598
[TBL] [Abstract][Full Text] [Related]
39. Trends in high deductible health plan enrolment and spending among commercially insured members with and without chronic conditions: a Natural Experiment for Translation in Diabetes (NEXT-D2) Study.
Garabedian LF; Zhang F; LeCates R; Wallace J; Ross-Degnan D; Wharam JF
BMJ Open; 2021 Sep; 11(9):e044198. PubMed ID: 34518242
[TBL] [Abstract][Full Text] [Related]
40. Impact of High-Deductible Health Plans on Medication Use Among Individuals With Bipolar Disorder.
Lu CY; Busch AB; Zhang F; Madden JM; Callahan MX; LeCates RF; Wallace J; Foxworth P; Soumerai SB; Ross-Degnan D; Wharam JF
Psychiatr Serv; 2021 Aug; 72(8):926-934. PubMed ID: 33971720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
